Caitlin Pham, NP
Nurse Practitioner · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
- Since medical school
- 9 years
- Graduated 2017
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Caitlin Pham’s office at (408) 241-3801 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$27,924
Medicare paid this office $27,924 for 293 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the | 63 | $18,904 | $62 |
| Anticoagulant management of patient taking warfarin | 231 | $4,683 | $8 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 62 | $1,767 | $6 |
| Short return visit (20+ min) | 11 | $625 | $57 |
Who their Medicare patients are
293 Original Medicare patients in 2024. Average age 81 · 85 and older 33% · Women 37% · Also on Medicaid 8% · Health risk score 1.58. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Atrial fibrillation 75% · Heart failure 39% · Coronary heart disease 38% · Chronic kidney disease 35% · Diabetes 30% · Cancer 13% · COPD 12% · Depression 11% · Stroke 10% · Dementia 9%.
The office billed $142,568, Medicare allowed $41,914 and paid $27,924; for 1,262 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 293 | 1,262 | 81 | 1.58 | $142,568 | $27,924 |
| 2023 | 332 | 3,411 | 81 | 1.54 | $285,850 | $64,867 |
| 2022 | 248 | 2,479 | 81 | 1.55 | $194,426 | $37,351 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the | 67 | $26,881 | $69 |
| Anticoagulant management of patient taking warfarin | 277 | $13,344 | $9 |
| Short return visit (20+ min) | 86 | $13,021 | $71 |
| Blood test, clotting time | 156 | $3,310 | $4 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 80 | $2,658 | $6 |
| New patient visit (45+ min) | 15 | $2,007 | $134 |
| Return visit (30+ min) | 16 | $1,664 | $104 |
| Short return visit | 23 | $1,070 | $41 |
2022: 5 services
| Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the | 46 | $20,458 | $50 |
| Blood test, clotting time | 211 | $4,440 | $4 |
| Short return visit (20+ min) | 36 | $4,272 | $70 |
| Anticoagulant management of patient taking warfarin | 141 | $3,502 | $8 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 75 | $3,103 | $6 |
Medicaid work
$0 in 2023
Medicaid paid $0 for 37 billed services this clinician did in 2023, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Anticoagulant management for a patient taking warfarin, must include review and interpretation of a new home, office, or lab international normalized ratio (INR) test result, patient instructions, dosage adjustment (as needed), and scheduling of additional test(s), when performed | 37 | $0 |
| 2023 | 37 | 1 | 13 | $0 |
| 2021 | 2,447 | 4 | 99 | $159,432 |
| 2020 | 1,646 | 8 | 129 | $88,009 |
| 2019 | 4,499 | 15 | 192 | $300,309 |
| 2018 | 1,304 | 8 | 141 | $125,897 |
See the largest Medicaid services in earlier years
2021
| Clinic visit/encounter, all-inclusive | 1,027 | $158,895 |
| Short return visit (20+ min) | 1,333 | $458 |
| Return visit (30+ min) | 73 | $80 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 14 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 573 | $86,934 |
| Short return visit (20+ min) | 765 | $752 |
| Return visit (30+ min) | 114 | $277 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 57 | $42 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 58 | $4 |
| Hemoglobin A1C level | 20 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 22 | $0 |
| Short return visit | 37 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 1,862 | $298,221 |
| Short return visit (20+ min) | 1,358 | $1,607 |
| Return visit (30+ min) | 279 | $319 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 285 | $56 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 24 | $51 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 17 | $32 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 106 | $13 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 14 | $10 |
| HEMOGLOBIN | 12 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 255 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure) | 113 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 13 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 806 | $125,755 |
| Short return visit (20+ min) | 354 | $142 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 16 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 37 | $0 |
| Screening test, pure tone, air only | 25 | $0 |
| Bilateral quantitative screening test of visual acuity | 28 | $0 |
| New patient visit (45+ min) | 12 | $0 |
| Return visit (30+ min) | 26 | $0 |
Drugs they prescribed that Part D paid
$14,669
Pharmacies billed $14,669 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 529) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
526 generic and fewer than 11 brand-name prescriptions · $14,669 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Warfarin | 186 | $6,597 | $13 |
| Enoxaparin | 19 | $2,727 | $109 |
Year by year
| 2024 | 529 | 195 | 0% (0) | None | $14,669 |
| 2023 | 500 | 197 | 0% (0) | 0% | $14,228 |
| 2022 | 348 | 147 | 0% (0) | None | $25,963 |
| 2021 | 394 | 56 | 0% (0) | None | $45,440 |
| 2020 | 455 | 73 | 0% (0) | None | $25,114 |
| 2019 | 573 | 78 | None | 20% | $35,426 |
| 2018 | 246 | 41 | None | 11% | $12,388 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Warfarin | 455 | $10,615 | $23 |
| Enoxaparin | 19 | $3,257 | $171 |
| Jantoven | 26 | $356 | $14 |
2022: 3 drugs
| Warfarin | 243 | $5,903 | $24 |
| Enoxaparin | 11 | $1,085 | $99 |
| Atorvastatin | 13 | $414 | $32 |
2021: 7 drugs
| Losartan | 39 | $570 | $15 |
| Amlodipine Besylate | 45 | $501 | $11 |
| Atorvastatin | 33 | $483 | $15 |
| Metformin | 29 | $203 | $7 |
| Levothyroxine | 13 | $203 | $16 |
| Lisinopril | 18 | $145 | $8 |
| Hydrochlorothiazide | 16 | $99 | $6 |
2020: 12 drugs
| Atorvastatin | 29 | $341 | $12 |
| Levothyroxine | 20 | $340 | $17 |
| Losartan | 28 | $283 | $10 |
| Metformin | 46 | $277 | $6 |
| Gabapentin | 12 | $210 | $17 |
| Amlodipine Besylate | 27 | $160 | $6 |
| Simvastatin | 17 | $156 | $9 |
| Fluticasone Propionate | 12 | $130 | $11 |
| Lisinopril | 11 | $113 | $10 |
| Glipizide | 17 | $97 | $6 |
| Hydrochlorothiazide | 15 | $94 | $6 |
| Metoprolol | 12 | $48 | $4 |
2019: 16 drugs
| Novolog | 11 | $3,222 | $293 |
| Ventolin Hfa | 19 | $1,094 | $58 |
| Levothyroxine | 26 | $334 | $13 |
| Metformin | 47 | $282 | $6 |
| Lisinopril | 33 | $247 | $7 |
| Amlodipine Besylate | 45 | $230 | $5 |
| Atorvastatin | 21 | $212 | $10 |
| Clopidogrel | 16 | $201 | $13 |
| Glipizide | 26 | $192 | $7 |
| Simvastatin | 27 | $179 | $7 |
| Losartan | 15 | $167 | $11 |
| Omeprazole | 17 | $150 | $9 |
| Gabapentin | 14 | $128 | $9 |
| Tamsulosin | 11 | $98 | $9 |
| Atenolol | 19 | $78 | $4 |
| Hydrochlorothiazide | 22 | $69 | $3 |
2018: 6 drugs
| Metformin | 26 | $158 | $6 |
| Atorvastatin | 13 | $134 | $10 |
| Amlodipine Besylate | 17 | $107 | $6 |
| Simvastatin | 18 | $85 | $5 |
| Hydrochlorothiazide | 21 | $80 | $4 |
| Glipizide | 18 | $65 | $4 |
Money from drug and device companies
$26 in 2024
A payment is not proof that care is biased.
| Abbott Laboratories | Merlin@Home | $26 | 1 payment
|
See the published payment
| Abbott Laboratories | Meals · 2024-02-26 | Merlin@Home | $26 |
Professional record
- NPI
- 1083128128
- Licence
- CA 95007445
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2017-11-28
- NPI last updated
- 2022-01-11
- NPI record certified
- 2022-01-11
This is when the NPI record was last certified, not a medical board exam.